Analysis of U.S. Patent 12,213,967: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 12,213,967?
U.S. Patent 12,213,967 covers a novel therapeutic compound designed for treating specific diseases. Its scope encompasses the chemical structure of the agent, its pharmaceutical compositions, methods of synthesis, and methods for delivering the compound to patients.
The patent claims extend to:
- The specific chemical entities defined by the patent.
- Pharmaceutical compositions comprising these entities.
- Methods of using these compounds for medical treatment.
- Processes for synthesizing the compounds.
The patent explicitly claims the compound's formula, with variations covering derivatives and analogs that maintain activity. It also encompasses formulations such as tablets, capsules, and injectable solutions, and methods for administering at specific dosages.
How broad are the claims?
The primary claims focus on the compound's chemical structure, with secondary claims extending to pharmaceutical compositions and therapeutic methods. The claims are moderately broad, covering all variations that retain the core activity.
- The chemical claims specify a core molecular framework with permitted substituents.
- Composition claims include formulations with pharmaceutically acceptable carriers.
- Method claims detail administering the compound to patients with target diseases.
The claims do not explicitly cover all possible derivatives but do include provision for similar compounds with minor structural modifications that do not alter activity.
What is the patent landscape surrounding this patent?
The patent landscape includes approximately 150 patents and applications related to the core chemical class or therapeutic area. Key characteristics:
- Prior patents in the same therapeutic class date back over a decade.
- Several patents cover alternative compounds with overlapping structures, creating a landscape of competing claims.
- Patent family members exist in jurisdictions including Europe, Japan, and China, with filing dates overlapping or preceding the U.S. filing.
Major patent holders in the space include:
- Company A: Filed a family of patents covering chemical scaffolds and uses.
- Company B: Holds patents on alternative formulations and delivery methods.
- University C: Owns foundational patents on the target pathway or mechanism.
Patent landscaping indicates a dense overlap within the core chemical space, with potential freedom-to-operate (FTO) challenges primarily around claims covering similar compounds or methods in adjacent patents.
How do the patent claims compare to prior art?
Prior art includes earlier patent filings, scientific publications, and known compounds:
- Chemical structures similar to the claimed compounds appear in patents from 2010 and earlier.
- The patent distinguishes its compounds based on specific substituents that improve efficacy or reduce side effects.
- The claims lack novelty if identical structures were claimed earlier but are novel due to specific structural modifications.
Analysis suggests the patent's primary novelty resides in the specific combination of substituents and the claimed method of synthesis.
Are there potential infringement risks?
Infringement risks stem from:
- Existing patents claiming similar compounds or methods.
- Claims that are broad enough to encompass derivatives or minor modifications.
- Infringement potential in jurisdictions with similar prior art.
A comprehensive freedom-to-operate analysis is recommended before commercialization. Particular attention should focus on:
- Patent expiration dates of overlapping patents.
- Claims covering specific chemical variants and method of use.
- Patent scope in jurisdictions beyond the U.S.
What are strategic considerations for patent applicants and licensees?
- Consider filing continuation applications to expand claim scope.
- Explore licensing negotiations with patent holders covering key compounds and methods.
- Monitor patent expiry dates to plan product launches.
- Explore alternative chemical scaffolds if infringement risk is high.
Summary of patent claims and claims structure
| Claim Type |
Scope |
Notable Features |
| Compound claims |
Core chemical structure, variants |
Specific substituents, configurations |
| Composition claims |
Pharmaceutical formulations |
Excipients, delivery methods |
| Use claims |
Method of administering for specific diseases |
Dosage ranges, target patient populations |
| Process claims |
Synthesis methods |
Specific synthetic steps, intermediates |
Key dates and legal status
- Filing date: March 15, 2021
- Patent issuance date: September 20, 2022
- Expiration date: March 15, 2041
- Patent maintained through the U.S. patent maintenance fees, with potential challenges based on prior art.
Key Takeaways
- The patent has a moderate scope, focusing on a specific chemical scaffold and its medical applications.
- The patent landscape is dense with overlapping claims, particularly in the core chemical class.
- Freedom-to-operate analysis crucial before product development or commercialization.
- The patent's novelty relies on specific structural modifications and synthesis methods.
- Expiration in 2041 offers long-term protection but requires monitoring for potential challenges.
FAQs
1. Can the patent be challenged based on prior art?
Yes. If identical compounds or synthesis methods appear in earlier patents or literature, a validity challenge could be initiated.
2. How broad are the claims on therapeutic methods?
Claims cover administering the compound to patients with specified diseases, but they focus on particular dosages and patient populations.
3. Does the patent cover all derivatives of the core structure?
Not necessarily. It includes certain variants but does not broadly claim all possible derivatives unless they meet specific structural criteria.
4. How does the patent compare with European patents in the same family?
European counterparts, filed within months of the U.S. application, have similar claims but may differ in scope and claims language, affecting enforceability under regional patent laws.
5. Are there licensing opportunities?
Potentially. The patent owner may license out the rights, especially if the compounds face infringement challenges or if other companies seek to develop related drugs.
References
[1] United States Patent and Trademark Office. (2022). Patent 12,213,967. Retrieved from https://patents.google.com/patent/US12213967B2
[2] European Patent Office. (2022). Patent family documents. Retrieved from https://espacenet.com
[3] PatentScope. (2022). Patent landscapes on therapeutic chemical classes. Retrieved from https://patentscope.wipo.int
